Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH

1 trials 1 recruiting Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

1 Recruiting

0 Completed trials

5 Countries active

2 Unique IMPs

N/A Results reported

Phase III

Oversight events:

2 serious breaches across 1 trial

View oversight register →

Top indications

Prostate cancer 1

Top IMPs

(2S)-2-[[(1S)-1-CARBOXY-5-[[(2S)-2-[[4-[[[(2S)-4-CARBOXY-2-[[(2S)-4-CARBOXY-2-[(6-(18F)FLUORANYLPYRIDINE-3-CARBONYL)AMINO]BUTANOYL]AMINO]BUTANOYL]AMINO]METHYL]BENZOYL]AMINO]-3-NAPHTHALEN-2-YLPROPANOYL]AMINO]PENTYL]CARBAMOYLAMINO]PENTANEDIOIC ACID 1 (3S,10S,14S)-1-[4-[[(2S)-4-CARBOXY-2-[(2S)-4-CARBOXY-2-(6-[18F] FLUOROPYRIDIN-3-AMIDO)BUTANAMIDO]BUTANAMIDO]METHYL]PHENYL]-3-[(NAPHTHALEN-2-YL)METHYL]-1,4,12-TRIOXO-2,5,11,13-TETRAAZAHEXADECANE-10,14,16-TRICARBOXYLIC ACID 1

All trials

1 total

[18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer Recruiting

2023-504026-19-01 Phase III 5 countries (2S)-2-[[(1S)-1-CARBOXY-5-[[(2S)-2-[[4-[[[(2S)-4-CARBOXY-2-[[(2S)-4-CARBOXY-2-[(…

Showing 1–1 of 1 trials

← All sponsors A–Z